Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 30 695.0 |
96 | EP file number | EAKZ | 03 79 4351.1 |
86 | WO file number | WAKZ | PCT/NL03/00621 |
97 | EP publication number | EPN | 1551415 |
87 | WO publication number | WPN | 2004022065 |
54 | Designation/title | TI | ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND 15-HYDROXYTESTOSTERON UND SEINE DERIVATE |
51 | IPC main class | ICM (ICMV) | A61K 31/56 (2006.01) |
22 | DE application date | DAT | Sep 5, 2003 |
96 | EP application date | EAT | Sep 5, 2003 |
86 | WO application date | WAT | Sep 5, 2003 |
43 | Date of first publication | OT | Mar 18, 2004 |
| Date of publication of grant | PET | Dec 23, 2009 |
71/73 | Applicant/owner | INH | Pantarhei Bioscience B.V., Zeist, NL |
72 | Inventor | IN | BUNSCHOTEN, Evert, Johannes, NL-5384 EV Heesch, NL; COELINGH BENNINK, Herman, Jan, 2202 Da Noordwijk, NL; VAN DER LINDEN, Rene, Frank, NL-3951 LB Maarn, NL |
| Address for service | | Nederlandsch Octrooibureau, 2502 LS DEN HAAG, NL |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 02078643 Sep 5, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001551415 Searchable text:
EP000001551415 Original document:
EP000001551415B1 Searchable text:
EP000001551415B1 Original document:
WO002004022065 Searchable text:
WO002004022065 |
43 | Date of first publication | EVT | Mar 18, 2004 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 25, 2018 (Show all update days)(Hide all update days)- Sep 29, 2012
- Date of the first transfer into DPMAregister
|